Runway Growth Q3 10-Q: NII $0.38/Share, $44M Realized Loss, NAV $11.94
RWAY sits 25% above its 52-week low of $5.19.
Summary
Runway Growth's Q3 10-Q shows $0.38 per share of net investment income covering the $0.33 dividend, but a $44.0 million nine-month realized loss from loan restructurings and two non-accrual positions weigh on the credit story. NAV held at $11.94 and the buyback was expanded to $30 million.
Key Events · Earnings and Guidance · RWAY
-
Q3 NII Covers Dividend
Net investment income of $15.9 million, or $0.38 per share, against a declared $0.33 quarterly dividend; total investment income was $40.6 million.
-
$44M Realized Loss on Restructurings
Nine-month net realized loss of $44.0 million, primarily from restructuring the Blueshift Labs and Marley Spoon loans, cut nine-month net increase in net assets from operations to $3.1 million.
-
Two Loans on Non-Accrual
Marley Spoon SE and Mingle Healthcare are on non-accrual, representing 3.74% of the portfolio at fair value ($39.8 million) and $7.1 million of forgone income.
-
NAV Flat, Leverage Down
NAV per share was $11.94 versus $11.91 at June 30, 2026; asset coverage ratio fell to 191% from 211% at year-end 2025, with $216.6 million of available liquidity.
Analysis · RWAY · Unknown
The headline numbers were already out via this morning's 8-K, but the 10-Q fills in what actually drove them. Net investment income of $15.9 million ($0.38 per share) covers the $0.33 dividend, yet a $44.0 million nine-month realized loss from restructuring the Blueshift Labs and Marley Spoon loans dragged total net increase in net assets from operations down to just $3.1 million for the nine months. NAV held at $11.94 and leverage fell to about 110% after $130.7 million of repayments, but the credit-quality picture is the story: two loans are on non-accrual (3.74% of the portfolio at fair value) and the asset coverage ratio slipped to 191% from 211% at year-end. The board also expanded the buyback to $30 million through September 2027, a modest support for a stock trading well below NAV.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, RWAY was trading at $6.51 on NASDAQ in the Unknown sector, with a market capitalization of approximately $256.5M. The 52-week trading range was $5.19 to $10.06. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.